Does REMODULIN Cause Infusion site erythema? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Infusion site erythema have been filed in association with REMODULIN. This represents 2.3% of all adverse event reports for REMODULIN.
16
Reports of Infusion site erythema with REMODULIN
2.3%
of all REMODULIN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Infusion site erythema From REMODULIN?
Of the 16 reports, 9 (56.3%) required hospitalization.
Is Infusion site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMODULIN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does REMODULIN Cause?
Death (95)
Dyspnoea (79)
Device related infection (64)
Drug dose omission (42)
Nausea (32)
Headache (30)
Diarrhoea (28)
Pulmonary arterial hypertension (28)
Vomiting (28)
Fluid retention (27)
What Other Drugs Cause Infusion site erythema?
TREPROSTINIL (2,990)
HUMAN IMMUNOGLOBULIN G (1,850)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (312)
AMBRISENTAN (308)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (213)
FOSCARBIDOPA\FOSLEVODOPA (157)
MACITENTAN (147)
EPOPROSTENOL (90)
RIOCIGUAT (80)
LECITHIN\POLOXAMER 407 (70)
Which REMODULIN Alternatives Have Lower Infusion site erythema Risk?
REMODULIN vs REPAGLINIDE
REMODULIN vs REPOTRECTINIB
REMODULIN vs REQUIP
REMODULIN vs RESLIZUMAB
REMODULIN vs RESMETIROM